Roche Tamiflu Labeled For Seasonal Prophylaxis With 42-Day Dosing Regimen
Roche/Gilead Tamiflu updated labeling includes data from a seasonal prophylaxis study in elderly nursing home residents who took oseltamivir for 42 days.
You may also be interested in...
Comprehensive Clinical Research has made several personnel changes in response to an FDA inspection that resulted in a June 5 warning letter
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011